SRX-3128

N/A

Report date: 2025/01/26 16:43:30
NME

Base Information

Drug NameSRX-3128
Drug Alias Namedual PI3K/PARP inhibitor (SignalRx)SRX-3128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsPoly (ADP-Ribose) polymerase inhibitors
TargetsPI3-kinase class IPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignalrx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSignalrx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A